Acetaldehyde, a flavoring compound found in many beverages and foods, appears to be a major underlying factor for the carcinogenicity of alcoholic beverages, especially for

CEL-SCI has begun a phase III clinical trial for Multikine, its flagship immunotherapy drug for head and neck cancer. The goal is to establish Multikine

Estrogen may increase the movement of precancerous cells in the mouth and thus promote the spread of the disease within the oral cavity, according to

Cigna Oral Health Integration Program now includes coverage for more conditions, including stroke, chronic kidney disease, head and neck cancer radiation, and organ transplants, the

NEW YORK (Reuters Health) – Care for U.S. patients with head and neck cancers deviates significantly from national guidelines, if the findings of a new

Patients who have a recurrence of oral squamous cell carcinoma tend to do worse if the new cancer appears at the same site early or

University of Manchester scientists have discovered for the first time an important new way in which the human papillomavirus (HPV) triggers cancer in what could

Zoledronic acid, a drug currently approved for osteoporosis treatment, has been shown to reduce bone loss in a study of mice with oral cancer, suggesting

The U.S. Food and Drug Administration (FDA) is calling for a complete redesign of cigarette packaging and advertising as part of its overall strategy to

The National Institute of Dental and Craniofacial Research, part of the National Institutes of Health, has awarded a two-year, $245,000 grant to a New York

When the human papillomavirus (HPV) is found in cancer tumors of the tonsil and base of the tongue, patients are more likely to survive following

Women who consume large amounts of alcoholic beverages and have low consumption of folates have a three times greater risk of developing oral cancers than